We are excited to be able to present final videos from this highly anticipated annual event, the 2020 Targeted Therapies Patient Forum. This year's...
Molecular Testing
Molecular Testing
If you have been NEWLY DIAGNOSED START HERE
Video Library
Cancer Journey:
Cancer Type:
Disease Learning:
We are excited to be able to present final videos from this highly anticipated annual event, the 2020 Targeted Therapies Patient Forum. This year's...
Cancer Journey:
Cancer Type:
Disease Learning:
We are happy to present the GRACE ASCO 2020 Lung Cancer Patient Education, News and Updates series. Dr. Jack West has a virtual discussion with...
Cancer Journey:
Cancer Type:
ASCO Lung Cancer Roundtable - NSCLC - Enhertu and the Potential for Treatment of HER2 Positive NSCLC
We are happy to present the GRACE ASCO 2020 Lung Cancer Patient Education, News and Updates series. Dr. Jack West has a virtual discussion with...
Cancer Journey:
Cancer Type:
From the Targeted Therapies Patient Forum 2019, Dr. Joshua Bauml and Dr. Joshua Sabari discuss RET, MET and BRAF, the initial treatment and acquired...
Cancer Journey:
Cancer Type:
Disease Learning:
- 1 of 15
- View More
Articles
GRACE is excited to share with you a partnership with Lilly Oncology to provide you information that reflects our shared interests. We are happy to...
Cancer Journey:
Cancer Type:
Christine M. Walko, Pharm.D., discusses how advancements in technology have improved the quality, cost and turnaround time for assessing genetic mutations in tumor tissue, and how this has helped to translate precision medicine into standard clinical practice.
Cancer Journey:
Cancer Type:
Disease Learning:
Dr. Edward S. Kim from the Levine Cancer Institute in Charlotte, NC discusses the feasibility of molecular marker testing and targeted therapy in the adjuvant or post-operative setting.
Cancer Journey:
Cancer Type:
Disease Learning:
Brendan Bietry of the Patient Advocate Foundation discusses the financial assistance programs available to lung cancer patients who receive targeted therapies.
Cancer Journey:
Cancer Type:
Disease Learning:
Dr. West moderates a question & answer session with Drs. Leora Horn and Greg Riely on issues of acquired resistance to targeted therapies for patients with advanced NSCLC that harbors a driver mutation.
Cancer Journey:
Cancer Type:
Disease Learning:
- 1 of 62
- View More
Community Forum
The Targeted Therapies Patient Forum from CancerGrace.org is finally here and FREE to anyone. Originally scheduled for earlier this year our forum is...
Cancer Journey:
Cancer Type:
Progression after 3 1/2 years on Tarceva. Tissue biopsy showed T790m negative. Any suggestions/experience on next steps? Onc suggesting I move to Afatinib or a Opdivo. PDL1 was tested and is <1%.
Cancer Journey:
Cancer Type: